Bilcare has signed a definitive agreement with United Drug plc, a Euro 1.7 billion revenue leading international provider of healthcare services. As per the agreement, United Drug will acquire Bilcare’s Global Clinical Supplies (GCS) businesses in the US and the UK for $61 million while Bilcare will retain its GCS business in Asia.
Besides, going forward, United Drug and Bilcare GCS Asia will work together to use their complementary resources to meet the needs of their customers across US, Europe and Asia.
The agreement is a significant win-win for Bilcare GCS’s customers and United Drug. It will allow Bilcare GCS Asia to leverage United Drug’s deep capabilities and resources in US and Europe and meet customer requirements in those regions. Further Bilcare GCS Asia will continue to build scale by being able to service the Asia specific needs of United Drug’s customers in US and Europe. Importantly, this agreement will allow Bilcare GCS Asia to focus its resources and better meet customer expectations of world-class services.
| Company Name | CMP |
|---|---|
| Supreme Industries | 3715.95 |
| Astral | 1590.45 |
| Finolex Inds | 173.80 |
| Nilkamal | 1321.40 |
| Jain Irrigation Sys | 33.18 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: